RS Research

RS Research is a clinical-stage biotechnology start-up developing novel smart nanomedicines with superior therapeutic index. The company has discovered a novel drug delivery platform which empowers its current development programs in various preclinical and clinical stages for targeted therapies. The proprietary drug delivery platform Sagitta® allows designing targeted drug candidates for different indications, which yields into development of RS Research's current portfolio as well as an outstanding co-development potential. RS Research has a GMP-certified production facility for clinical development and has been successfully conducting co-development projects with its international partners. The company's lead candidate RS-0139 is currently studied under the clinical Phase I in oncology patients.

Domain

rsresearch.net

Country

Turkey

Employees

11-50

Last Funding

$0.1M

Founded

2015

Frequently Asked Questions

What technologies does RS Research use?+

RS Research uses 17 technologies including Elementor, Font Awesome, Google Analytics.

What industry is RS Research in?+

RS Research operates in the Biotechnology industry.

Where is RS Research based?+

RS Research is headquartered in Turkey.

Need this data at scale?

Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.

Browse Datasets

Data last updated: June 2026